{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:31:55Z","timestamp":1777307515828,"version":"3.51.4"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Guidelines endorse specific life expectancy (LE) cutoffs for triage of definitive local treatment of prostate cancer, but the lack of validated, prostate cancer-specific LE prediction tools limits incorporation of LE in management decisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We sought to provide long-term LE predictions in older men using the Prostate Cancer Comorbidity Index (PCCI), a validated tool for prediction of other-cause mortality based on age and presence and severity of major comorbidities, in nationally representative cohorts of US prostate cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, Subjects<\/jats:title>\n                    <jats:p>We performed an observational study of 916,890 men in the SEER-Medicare database and 243,928 men in the VA diagnosed with clinically localized prostate cancer between 2000 and 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PCCI scores were calculated using ICD-9 and ICD-10 codes. Kaplan Meier and multivariable Cox proportional hazards analysis were used to measure overall survival by age-adjusted PCCI score groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Median follow up was 11\u00a0years in both cohorts. In SEER-Medicare, men with PCCI scores of 1\u20132, 3\u20134, 5\u20136, 7\u20139, and 10+ had median estimated LE (95%CI) of 16.6 (16.5\u201316.7), 12.2 (12.1\u201312.2), 10.7 (10.6\u201310.7), 9.3 (9.2\u20139.3), and 5.4 (5.3\u20135.4) years, respectively. In the VA, men with the same PCCI scores had estimated median LE (95%CI) of 16.1 (16.0\u201316.3), 11.2 (11.1\u201311.4), 9.1 (8.9\u20139.2), 7.5 (7.4\u20137.7), and 5.2 (5.0\u20135.3) years, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The PCCI robustly predicts long-term longevity in SEER-Medicare and VA populations, with similar LE estimates in each. LE prediction tables with their accompanying variability estimates can help clinicians implement guidelines endorsed LE cutoffs for management of older men with prostate cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ageing\/afag097","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T11:32:27Z","timestamp":1777116747000},"source":"Crossref","is-referenced-by-count":0,"title":["Life expectancy estimation in older men using the prostate cancer comorbidity index in VA &amp; SEER-Medicare cohorts"],"prefix":"10.1093","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0117-7978","authenticated-orcid":false,"given":"John","family":"Heard","sequence":"first","affiliation":[{"name":"Cedars-Sinai Medical Center \u2013 Department of Urology , Cedars-Sinai Medical Center, Los Angeles, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7968-7313","authenticated-orcid":false,"given":"Michael","family":"Luu","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center \u2013 Department of Biostatistics , Cedars-Sinai Medical Center, Los Angeles, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Chun","family":"Thomas","sequence":"additional","affiliation":[{"name":"Stanford University \u2013 Department of Urology , Stanford University, Stanford, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Leppert","sequence":"additional","affiliation":[{"name":"Stanford University \u2013 Department of Urology , Stanford University, Stanford, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Daskivich","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center \u2013 Department of Urology , Cedars-Sinai Medical Center, Los Angeles, California ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"2026042711322083800_ref1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cct.2008.08.002","article-title":"The prostate cancer intervention versus observation trial:VA\/NCI\/AHRQ cooperative studies program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer","volume":"30","author":"Wilt","year":"2009","journal-title":"Contemp Clin Trials"},{"key":"2026042711322083800_ref2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.7326\/0003-4819-158-10-201305210-00005","article-title":"Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer","volume":"158","author":"Daskivich","year":"2013","journal-title":"Ann Intern Med"},{"key":"2026042711322083800_ref3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/pcan.2010.33","article-title":"From bad to worse: comorbidity severity and quality of life after treatment for early-stage prostate cancer","volume":"13","author":"Daskivich","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2026042711322083800_ref4","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1002\/cncr.28926","article-title":"Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer","volume":"120","author":"Daskivich","year":"2014","journal-title":"Cancer."},{"key":"2026042711322083800_ref5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"2026042711322083800_ref6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"key":"2026042711322083800_ref7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1001\/jamainternmed.2024.5994","article-title":"Overtreatment of men with prostate cancer and limited longevity in the active surveillance era","volume":"185","author":"Daskivich","year":"2024","journal-title":"JAMA Intern Med"},{"key":"2026042711322083800_ref8","doi-asserted-by":"publisher","first-page":"e258572","DOI":"10.1001\/jamanetworkopen.2025.8572","article-title":"Radical treatment for prostate cancer in men with limited life expectancy in Sweden","volume":"8","author":"Ventimiglia","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026042711322083800_ref9","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.juro.2012.11.174","article-title":"Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a National Survey of radiation oncologists and urologists","volume":"189","author":"Kim","year":"2013","journal-title":"J Urol"},{"key":"2026042711322083800_ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-025-10062-2","article-title":"Physician preferences regarding integration of life expectancy in prostate cancer management","author":"Heard","year":"2026","journal-title":"J Gen Intern Med"},{"key":"2026042711322083800_ref11","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41391-022-00550-5","article-title":"Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomy","volume":"26","author":"Chen","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2026042711322083800_ref12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/JU.0000000000000287","article-title":"External validation of the prostate cancer specific comorbidity index: a claims based tool for the prediction of life expectancy in men with prostate cancer","volume":"202","author":"Daskivich","year":"2019","journal-title":"J Urol"},{"key":"2026042711322083800_ref13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.juro.2015.01.081","article-title":"An age adjusted comorbidity index to predict long-term, other cause mortality in men with prostate cancer","volume":"194","author":"Daskivich","year":"2015","journal-title":"J Urol"},{"key":"2026042711322083800_ref14","volume-title":"International Classification of Diseases, (ICD-10-CM\/PCS) Transition \u2013 Background","author":"US Centers for Disease Control and Prevention; National Center for Health Statistics"},{"key":"2026042711322083800_ref15","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"2026042711322083800_ref16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1001\/jamainternmed.2024.5994","article-title":"Overtreatment of prostate cancer among men with limited longevity in the active surveillance era. JAMA","volume":"185","author":"Daskivich","year":"2024","journal-title":"Intern Med"},{"key":"2026042711322083800_ref17","doi-asserted-by":"publisher","first-page":"e258576","DOI":"10.1001\/jamanetworkopen.2025.8576","article-title":"Overtreatment of prostate cancer in men with limited life expectancy-a global phenomenon?","volume":"8","author":"Daskivich","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026042711322083800_ref18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.clgc.2023.07.001","article-title":"National Trends in Management of Newly Diagnosed Prostate Cancer","volume":"22","author":"Maganty","year":"2024","journal-title":"Clin Genitourin Cancer"},{"key":"2026042711322083800_ref19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2026042711322083800_ref20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.juro.2018.06.008","article-title":"Ethical pitfalls when estimating life expectancy for patients with prostate cancer","volume":"200","author":"Leppert","year":"2018","journal-title":"J Urol"},{"key":"2026042711322083800_ref21","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1001\/archinte.160.21.3252","article-title":"Are patients at veterans affairs medical Centers sicker?","volume":"160","author":"Agha","year":"2000","journal-title":"Arch Intern Med"},{"key":"2026042711322083800_ref22","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare9050604","article-title":"Exploring health outcomes for U.S. veterans compared to non-veterans from 2003 to 2019","volume":"9","author":"Betancourt","year":"2021","journal-title":"Healthcare."},{"key":"2026042711322083800_ref23","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1002\/cncr.26104","article-title":"Comorbidity and competing risks for mortality in men with prostate cancer","volume":"117","author":"Daskivich","year":"2011","journal-title":"Cancer."},{"key":"2026042711322083800_ref24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.urology.2014.07.003","article-title":"Prediction of long-term other-cause mortality in men with early-stage prostate cancer: results from the prostate cancer outcomes study","volume":"85","author":"Daskivich","year":"2015","journal-title":"Urology."},{"key":"2026042711322083800_ref25","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.juro.2010.10.061","article-title":"Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden","volume":"185","author":"Berglund","year":"2011","journal-title":"JJ Urol"},{"key":"2026042711322083800_ref26","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1001\/jama.2018.5616","article-title":"Use of conservative management for low-risk prostate Cancer in the veterans affairs integrated health care system from 2005-2015","volume":"319","author":"Loeb","year":"2018","journal-title":"JAMA."},{"key":"2026042711322083800_ref27","doi-asserted-by":"publisher","volume-title":"J Natl Compr Canc Netw","author":"","DOI":"10.6004\/jnccn.2025.0052"},{"key":"2026042711322083800_ref28","doi-asserted-by":"publisher","first-page":"e231439","DOI":"10.1001\/jamanetworkopen.2023.1439","article-title":"Time trends and variation in the use of active surveillance for management of low-risk prostate Cancer in the US","volume":"6","author":"Cooperberg","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026042711322083800_ref29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/JU.0000000000002675","article-title":"Variation in communication of competing risks of mortality in prostate cancer treatment consultations","volume":"208","author":"Daskivich","year":"2022","journal-title":"J Urol"},{"key":"2026042711322083800_ref30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jamasurg.2021.5803","article-title":"Patient preferences for communication of life expectancy in prostate cancer treatment consultations","volume":"157","author":"Daskivich","year":"2022","journal-title":"JAMA Surg"},{"key":"2026042711322083800_ref31","doi-asserted-by":"publisher","first-page":"e0240039","DOI":"10.1371\/journal.pone.0240039","article-title":"Predicting the 10-year risk of death from other causes in men with localized prostate cancer using patient-reported factors: development of a tool","volume":"15","author":"Frendl","year":"2020","journal-title":"PloS One"},{"key":"2026042711322083800_ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0572-z","article-title":"Successful external validation of a model to predict other cause mortality in localized prostate cancer","volume":"14","author":"Kent","year":"2016","journal-title":"BMC Med"},{"key":"2026042711322083800_ref33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.urology.2021.05.056","article-title":"Using an automated electronic health record score to estimate life expectancy In men diagnosed with prostate cancer In the veterans health administration","volume":"155","author":"Soerensen","year":"2021","journal-title":"Urology."},{"key":"2026042711322083800_ref34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4236\/jbise.2022.1511023","article-title":"Insights into the social determinants of health in older adults","volume":"15","author":"Perez","year":"2022","journal-title":"Journal of Biomedical Science and Engineering"},{"key":"2026042711322083800_ref35","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1007\/s11606-014-3171-8","article-title":"Self-reported health status predicts other-cause mortality in men with localized prostate cancer: results from the prostate cancer outcomes study","volume":"30","author":"Hoffman","year":"2015","journal-title":"J Gen Intern Med"},{"key":"2026042711322083800_ref36","doi-asserted-by":"publisher","first-page":"e183605","DOI":"10.1001\/jamanetworkopen.2018.3605","article-title":"Association of Cardiorespiratory Fitness with long-term mortality among adults undergoing exercise treadmill testing","volume":"1","author":"Mandsager","year":"2018","journal-title":"JAMA Netw Open"},{"key":"2026042711322083800_ref37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/07853890.2020.1748220","article-title":"Handgrip strength is inversely associated with fatal cardiovascular and all-cause mortality events","volume":"52","author":"Laukkanen","year":"2020","journal-title":"Ann Med"},{"key":"2026042711322083800_ref38","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/cncr.33341","article-title":"Laboratory-wide association study of survival with prostate cancer","volume":"127","author":"Sohlberg","year":"2021","journal-title":"Cancer."},{"key":"2026042711322083800_ref39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/bmjspcare-2013-000488","article-title":"Development and evaluation of the supportive and palliative care indicators tool (SPICT): a mixed-methods study","volume":"4","author":"Highet","year":"2014","journal-title":"BMJ Supportive &amp; Palliative Care"},{"key":"2026042711322083800_ref40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1089\/jpm.2010.0347","article-title":"Identifying patients in need of a palliative care assessment in the hospital setting a consensus report from the Center to advance palliative care","volume":"14","author":"Weissman","year":"2011","journal-title":"J Palliat Med"},{"key":"2026042711322083800_ref41","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.m146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026042711322083800_ref42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s0140-6736(98)04402-x","article-title":"A brief clinical instrument to classify frailty in elderly people","volume":"353","author":"Rockwood","year":"1999","journal-title":"The Lancet"},{"key":"2026042711322083800_ref43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/bf02982161","article-title":"The I.A.N.A. task force on frailty assessment of older people in clinical practice","volume":"12","author":"Van Kan","year":"2008","journal-title":"The Journal of nutrition, health and aging"},{"key":"2026042711322083800_ref44","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1056\/NEJMoa1807801","article-title":"Radical prostatectomy or watchful waiting in prostate cancer - 29-year follow-up","volume":"379","author":"Bill-Axelson","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/55\/4\/afag097\/68166775\/afag097.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/55\/4\/afag097\/68166775\/afag097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:32:30Z","timestamp":1777303950000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article\/doi\/10.1093\/ageing\/afag097\/8663060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afag097","relation":{},"ISSN":["0002-0729","1468-2834"],"issn-type":[{"value":"0002-0729","type":"print"},{"value":"1468-2834","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,4]]},"article-number":"afag097"}}